#1089 Bevacizumab for recurrent, persistent or advanced cervical cancer: experience of three portuguese institutions | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Poster/ePoster Sessions

01. Cervical cancer

#1089 Bevacizumab for recurrent, persistent or advanced cervical cancer: experience of three portuguese institutions

Free

Online download statistics by month:

Online download statistics by month: September 2023 to October 2024

	Abstract	Full	Pdf
Sep 2023	18	0	3
Oct 2023	74	0	8
Nov 2023	96	0	4
Dec 2023	25	0	4
Jan 2024	2	0	0
Feb 2024	10	0	2
Mar 2024	19	0	2
Apr 2024	26	0	3
May 2024	32	0	8
Jun 2024	17	0	1
Jul 2024	14	0	4
Aug 2024	12	0	1
Sep 2024	15	0	5
Oct 2024	4	0	0
Total	364	0	45